Ampersand invests in MedPharm

Ampersand Capital Partners has made an investment in MedPharm, a developer of topical and transdermal products for drug developers. No financial terms were disclosed.

26 March 2018•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles